Aptus Pharma Board Meeting on June 12 to Discuss Fund Raising

Aptus Pharma Ltd has announced a Board of Directors meeting scheduled for June 12, 2026. The primary agenda items include considering and approving proposals for raising funds through preferential allotment of equity shares and/or other securities, as well as potential borrowings from banks and financial institutions. The Board will also discuss authorizing the Managing Director to engage with potential investors and lenders. Additionally, the company will inform about the closure of the trading window from June 9, 2026, until 48 hours after the board meeting outcome is disseminated, in compliance with SEBI regulations.